Clinical Trials Directory

Trials / Completed

CompletedNCT03780985

Post-placental Intrauterine Device Insertion During Cesarean Section

Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
118 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The traditional 6-week postpartum visits not evidenced based and may not meet patient needs, particularly with respect to provision of contraception.Intrauterine device placement after delivery of the placenta is an appealing strategy for increasing access to postpartum Intrauterine device because it does not require a separate postpartum visit. Advantage of post-placental Intrauterine device insertion, Intrauterine devices are recommended as first-line contraceptives by the American Academy of Pediatricians. The Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for Contraceptive Use places no restrictions on use, and states advantages generally outweigh the risks for immediate postpartum use of Intrauterine devices.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntrauterine device insertionPost-placental insertion of intrauterine device during Cesarean section
PROCEDURECesarean sectionto delivery of the fetus
PROCEDURESutureto fix the intrauterine device

Timeline

Start date
2019-01-01
Primary completion
2020-02-01
Completion
2020-04-01
First posted
2018-12-19
Last updated
2021-09-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03780985. Inclusion in this directory is not an endorsement.